Ketamine clinics for depression offer Ketamine-assisted treatments for major depression; sufferers of depression that have resisted previous forms of medicated treatment are the best candidates for this type of treatment. In the US, the Food and Drug Administration (FDA) has approved a drug, based on Ketamine, for the treatment of people with severe depression.
Esketamine is administered in the form of a nasal spray; it was approved because it showed that depressive symptoms in individuals could be relieved within hours of use. The drug is the first drug of its kind approved within the last 30 years, highlighting the potential that it possesses. In the UK, some groups, such as our Save Minds Clinics, offer Ketamine-assisted treatment for those suffering major depression. However, because the nasal spray has not been approved in the UK, it has to be administered through intravenous infusion, a process that is significantly more labour intensive.